Euromedis Groupe (ALEMG.PA)
EUR 4.45
(0.23%)
EUR 4.45
(0.23%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | -1.04 Million | 19.24 Million | 13.5 Million | 965 Thousand | -1.63 Million |
| Net Income | 13.11 Million | -5.93 Million | 2.3 Million | 22.86 Million | -3.79 Million | -4.91 Million |
| Depreciation & Amortization | - | 1 Million | -1.99 Million | 5.15 Million | 3 Million | 1.73 Million |
| Deferred income taxes | - | -10 Thousand | 44 Thousand | 832 Thousand | 6000.00 | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | 3.88 Million | 15.66 Million | -15.53 Million | 804 Thousand | -111.52 Thousand |
| Other non-cash items | -13.11 Million | -1000.00 | 3.27 Million | 1.02 Million | 951 Thousand | 1.66 Million |
| Investing Cash Flow | - | -1.07 Million | -1.13 Million | -592 Thousand | -1.51 Million | -1.32 Million |
| Investments in PPE | - | -1.03 Million | -1.83 Million | -660 Thousand | -1.56 Million | -1.37 Million |
| Acquisitions | - | -60 Thousand | 403 Thousand | 7000.00 | 2000.00 | -4235.00 |
| Investment purchases | - | 60 Thousand | -403 Thousand | -7000.00 | - | - |
| Sales/Maturities of investments | - | 22 Thousand | 434 Thousand | 61 Thousand | - | - |
| Other Investing Activities | - | -60 Thousand | 273 Thousand | 7000.00 | 51 Thousand | 57.17 Thousand |
| Financing Cash Flow | - | -2.4 Million | -1.24 Million | 9.29 Million | 1.8 Million | 792 Thousand |
| Debt repayment | - | -2.15 Million | -1.29 Million | -10.62 Million | -3.41 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | -277 Thousand | - | -89 Thousand | - | - |
| Common Stock Issuance | - | - | 21 Thousand | - | 22 Thousand | - |
| Other Financing Activities | - | 30 Thousand | 30 Thousand | 20 Million | 5.2 Million | 792 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | 3.88 Million | 15.66 Million | -15.53 Million | 804 Thousand | -111.52 Thousand |
| Cash at beginning of period | 26.8 Million | 31.32 Million | 14.45 Million | -7.74 Million | -9 Million | -5.95 Million |
| Cash at end of period | 26.8 Million | 26.8 Million | 31.32 Million | 14.45 Million | -7.74 Million | -8.11 Million |
| Capital Expenditure | - | -1.03 Million | -1.83 Million | -660 Thousand | -1.56 Million | -1.37 Million |
| Effect of forex changes on cash | - | - | 1000.00 | - | 1000.00 | - |
| Net cash flow / Change in cash | - | -4.52 Million | 16.86 Million | 22.2 Million | 1.25 Million | -2.16 Million |
| Free Cash Flow | - | -2.08 Million | 17.4 Million | 12.84 Million | -602 Thousand | -3 Million |
| Breakdown | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -532 Thousand | 9.33 Million | 13.11 Million | 9.33 Million | -5.56 Million | -2.78 Million |
| Depreciation & Amortization | 106 Thousand | - | - | - | 665 Thousand | 332.5 Thousand |
| Deferred income taxes | - | - | - | - | 12 Thousand | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 1.21 Million | - | - | - | 1.18 Million | 594.5 Thousand |
| Other non-cash items | 7000.00 | -9.33 Million | -13.11 Million | -9.33 Million | 2.84 Million | 749 Thousand |
| Investing Cash Flow | -21 Thousand | - | - | - | -1.24 Million | -620.5 Thousand |
| Investments in PPE | -21 Thousand | - | - | - | -1.21 Million | -607 Thousand |
| Acquisitions | - | - | - | - | -40 Thousand | -20 Thousand |
| Investment purchases | - | - | - | - | 23.5 Thousand | - |
| Sales/Maturities of investments | - | - | - | - | 3000.00 | - |
| Other Investing Activities | - | - | - | - | 6500.00 | 6500.00 |
| Financing Cash Flow | -954 Thousand | - | - | - | -1.2 Million | -588 Thousand |
| Debt repayment | -988 Thousand | - | - | - | -1.08 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | -125 Thousand | -62.5 Thousand |
| Common Stock Issuance | 34 Thousand | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | -525.5 Thousand | -525.5 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 1.21 Million | - | - | - | 594.5 Thousand | 594.5 Thousand |
| Cash at beginning of period | 22.17 Million | - | 26.8 Million | - | 26.8 Million | - |
| Cash at end of period | 18.66 Million | - | 26.8 Million | - | 22.17 Million | -2.31 Million |
| Capital Expenditure | -21 Thousand | - | - | - | -1.21 Million | -607 Thousand |
| Effect of forex changes on cash | - | - | - | - | 1000.00 | - |
| Net cash flow / Change in cash | -3.5 Million | - | - | - | -4.63 Million | -2.31 Million |
| Free Cash Flow | 775 Thousand | - | - | - | -3.39 Million | -1.71 Million |
5243
FORA
603267
7161
600329
KRDXF